Effectiveness of an Inactivated SARS-CoV-2 Vaccine.

Wilder-Smith, Annelies; Mulholland, Kim

Wilder-Smith, Annelies; Mulholland, Kim.

Wilder-Smith A; From the Institute of Social and Preventive Medicine, University of Bern, Switzerland (A.W.-S.); Murdoch Children's Research Institute, Melbourne, VIC, Australia (K.M.); and the London School of Hygiene and Tropical Medicine, London (K.M.).
Mulholland K; From the Institute of Social and Preventive Medicine, University of Bern, Switzerland (A.W.-S.); Murdoch Children's Research Institute, Melbourne, VIC, Australia (K.M.); and the London School of Hygiene and Tropical Medicine, London (K.M.).

N Engl J Med ; 385(10): 946-948, 2021 09 02.

Article in English | MEDLINE | ID: covidwho-1380920

Subject(s)

COVID-19 Vaccines/immunology; COVID-19/prevention & control; Immunogenicity, Vaccine; Mass Vaccination; Vaccines, Inactivated; COVID-19/epidemiology; Chile/epidemiology; Disease Transmission, Infectious/prevention & control; Hospitalization/statistics & numerical data; Humans; Incidence; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines, Inactivated / Mass Vaccination / Immunogenicity, Vaccine / COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study Topics: Vaccines Limits: Humans Country/Region as subject: South America / Chile Language: English Journal: N Engl J Med Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google